RFA Financial Inc. ("RFA" or the "Company") (TSX: RFA) (OTCQX: RFAFF) announced today that it has qualified to trade in the United States ("U.S.") on the OTCQX Best Market ("OTCQX") under the ticker ...

MOUNT PLEASANT, MI / ACCESS Newswire / February 26, 2026 / Isabella Bank Corporation (Nasdaq:ISBA) today announced its Board of Directors declared a first-quarter cash dividend of $0.28 per common ...

The financial information reported in this document is based on the unaudited interim condensed consolidated financial statements for the quarter ended January 31, 2026 and is prepared in ...

The Phase 1 clinical study is expected to enroll approximately 24 healthy adult volunteers. The primary objectives of the study are to characterize the pharmacokinetic release profile of the nalmefene ...

NANTES, France, February 26, 2026 – 6pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced that the Independent Data Monitoring Committee (IDMC) has issued a second ...

5th new project launch from the start of the new year highlights rapid follow-on expansion through established regional ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ('Adial” or the 'Company”), a clinical-stage biopharmaceutical company focused on ...

Marks 17th New Service Provider Partnership Since Mid-2024 and Continues Track Record of Incumbent Displacement ...

Dead languages aren't as unimportant as they seem, because learning Latin, Sanskrit and Ancient Greek will make coding easier ...

CNW/ - National Bank of Canada (the "Bank") (TSX: NA) announced today that its Board of Directors has authorized an amendment ...

Non-GAAP adjusted EBITDA for the quarter ended December 31, 2025 was $37.3 million, or 40% of net revenue, compared to $29.9 million, or 40% of net revenue, for the fourth quarter of 2024. A table ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...